Abciximab
Effects of Abciximab Studied in Whole Blood in vitro
Published in Blood Weekly, March 30th, 2000
"The aim of this study was to compare fibrinogen binding, inhibition of platelet aggregation and secretory potential of the MAb abciximab (0.5-5 (mu)g/mL) and the peptidomimetic compound SR121-566A (15-250 ng/mL) in vitro in whole blood," wrote U. Klinkhardt and colleagues, University Hospital, Germany.
Klinkhardt et al. published their study in Thrombosis Research ("Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters," Thromb Res,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2000-03-30)
More Articles from Blood Weekly
- Thromboembolism
Heparin for Thromboembolic Event May Mean More Transfusions - Burn Injury
Interleukin-12 Increases Survival after Septic Challenge - Familial Hypercholesterolemia
LDL Receptor Mutation Alters Lipoprotein(a) Concentrations - Hemodialysis
Anemia Management Needs Improvement - Hemorrhagic Shock
Naloxone May Cause Deleterious Effects - Leukemia
Blood Cell Transplant Results in Rapid Hematologic Recovery - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
